Systemic inflammation and tumour-infiltrating T-cell receptor repertoire diversity are predictive of clinical outcome in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
- Language
-
Englisch
- Identifier
-
126900431X
Subject
Krebs ; B-Zell-Lymphom; Immuntherapie
Contributor
Olschewski, Vito
Witte, Hanno M.
Bernard, Veronica
Steinestel, Konrad
Peter, Wolfgang
Merz, Hartmut
Rieken, Johannes
Biersack, Harald
von Bubnoff, Nikolas
Feller, Alfred C.
Gebauer, Niklas
Witte, Hanno M.
Bernard, Veronica
Steinestel, Konrad
Peter, Wolfgang
Merz, Hartmut
Rieken, Johannes
Biersack, Harald
von Bubnoff, Nikolas
Feller, Alfred C.
Gebauer, Niklas
- DOI
-
10.18725/OPARU-44786
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
27.10.2022, 11:05 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Olschewski, Vito
- Witte, Hanno M.
- Bernard, Veronica
- Steinestel, Konrad
- Peter, Wolfgang
- Merz, Hartmut
- Rieken, Johannes
- Biersack, Harald
- von Bubnoff, Nikolas
- Feller, Alfred C.
- Gebauer, Niklas
Other Objects (12)
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Pelger-Huët anomaly and T-cell lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Clonal Haematopoiesis in Patients with angioimmunoblastic T-Cell Lymphoma
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Pelger-Huët anomaly and T-cell lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Clonal Haematopoiesis in Patients with angioimmunoblastic T-Cell Lymphoma
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Pelger-Huët anomaly and T-cell lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Clonal Haematopoiesis in Patients with angioimmunoblastic T-Cell Lymphoma
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma